Abstract
Systemic infections due to Mycoplasma hominis are rare and occur mainly in immunocompromised patients. Reported here are the cases of two renal transplant patients with peritonitis who did not respond to empirical antimicrobial treatment. Effective treatment with doxycycline was administered only after definitive identification of Mycoplasma hominis was achieved. For this identification, the new genetic amplification-sequencing method was invaluable.
Similar content being viewed by others
References
Waites KB, Rikihisa Y, Taylor-Robinson D (2003) Mycoplasma and Ureaplasma. In: Murray PR, Baron EJ, Jorgensen JM, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology. American Society for Microbiology, pp 972–990
Pastural M, Audard V, Bralet MP, Remy P, Salomon L, Tankovic J, Buisson CB, Lang P (2002) Mycoplasma hominis infection in renal transplantation. Nephrol Dial Transplant 17:495–496
Filthuth I, Emler S, Jacobs E, Auckenthaler R (1996) Isolation of Mycoplasma hominis on CDC anaerobic blood agar. Eur J Clin Microbiol Infect Dis 15:896–897
Geissdorfer W, Schorner C, Lohoff M (2001) Systemic Mycoplasma hominis infection in a patient immunocompromised due to combined transplantation of kidney and pancreas. Eur J Clin Microbiol Infect Dis 20:511–512
Bijl AE van der, Kamper AM, Fijter JW de, Paul LC (2000) Mycoplasma hominis peritonitis after renal transplantation. Nephron 86:541–542
Goldenberger D, Kunzli A, Vogt P, Zbinden R, Altwegg M (1997) Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 35:2733–2739
Kiratisin P, Li L, Murray PR, Fischer SH (2003) Identification of bacteria recovered from clinical specimens by 16S rRNA gene sequencing. Eur J Clin Microbiol Infect Dis 22:628–631
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rohner, P., Schnyder, I., Ninet, B. et al. Severe Mycoplasma hominis Infections in Two Renal Transplant Patients. Eur J Clin Microbiol Infect Dis 23, 203–204 (2004). https://doi.org/10.1007/s10096-003-1097-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-003-1097-x